Heinen und Löwenstein GmbH & Co. KG
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Efficacy of Telemetry-assisted Care in Home Home Vented COPD
Role: collaborator
Effects of Telemedical Support on Therapeutic Results of CPAP Patients
Role: collaborator
Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography
Role: collaborator
Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants
Role: collaborator
Application of Forced Breath Technique While CPAP Therapy for Apnea Classification
Role: lead
Extended Evaluation of the Efficacy of a Proactive FOT-based Auto-CPAP Algorithm
Role: lead
All 6 trials loaded